These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2985361)

  • 41. Visualization of lipoprotein receptors by ligand blotting.
    Daniel TO; Schneider WJ; Goldstein JL; Brown MS
    J Biol Chem; 1983 Apr; 258(7):4606-11. PubMed ID: 6300091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covalent cross-linking of growth hormone-releasing factor to pituitary receptors.
    Veliçelebi G; Patthi S; Provow S; Akong M
    Endocrinology; 1986 Apr; 118(4):1278-83. PubMed ID: 3004907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presence of luteinizing hormone releasing hormone (LHRH) in milk.
    Smith SS; Ojeda SR
    Endocrinol Exp; 1986 Aug; 20(2-3):147-53. PubMed ID: 3019631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solubilization of the gonadotropin-releasing hormone receptor from bovine pituitary plasma membranes.
    Perrin MH; Haas Y; Rivier JE; Vale WW
    Endocrinology; 1983 Apr; 112(4):1538-40. PubMed ID: 6299698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothalamic regulation of pituitary gonadotropin-releasing hormone receptors: effects of gonadotropin-releasing hormone immunoneutralization.
    Clayton RN; Popkin RM; Fraser HM
    Endocrinology; 1982 Apr; 110(4):1116-22. PubMed ID: 6277595
    [No Abstract]   [Full Text] [Related]  

  • 50. Solubilization and purification of rat pituitary gonadotropin-releasing hormone receptor.
    Hazum E; Schvartz I; Waksman Y; Keinan D
    J Biol Chem; 1986 Oct; 261(28):13043-8. PubMed ID: 3020021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new antiserum with conformational specificity for LHRH: usefulness for radioimmunoassay and immunocytochemistry.
    Ellinwood WE; Ronnekleiv OK; Kelly MJ; Resko JA
    Peptides; 1985; 6(1):45-52. PubMed ID: 3887335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attempts to immunoprecipitate the LHRH precursor synthesized in cell free systems.
    Cohen S; Charli JL; Díaz de León L; Millar RP; Arimura A; Morrison MR; Joseph-Bravo P
    Brain Res Bull; 1986 Mar; 16(3):309-14. PubMed ID: 2423199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simple and rapid anti-ligand enzyme immunoassay for visualization of low-density lipoprotein membrane receptors.
    Dresel HA; Otto I; Weigel H; Schettler G; Via DP
    Biochim Biophys Acta; 1984 Oct; 795(3):452-7. PubMed ID: 6477955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human placental LHRH receptor: agonist and antagonist labeling produces differences in the size of the non-denatured, solubilized receptor.
    Escher E; Mackiewicz Z; Lagacé G; Lehoux JG; Gallo-Payet N; Bellabarba D; Bélisle S
    J Recept Res; 1988; 8(1-4):391-405. PubMed ID: 2838623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gonadotropin-releasing hormone binding sites in human breast carcinoma.
    Eidne KA; Flanagan CA; Millar RP
    Science; 1985 Sep; 229(4717):989-91. PubMed ID: 2992093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solubilization of neuropeptide receptors.
    Perrin MH
    Methods Enzymol; 1986; 124():164-71. PubMed ID: 3012247
    [No Abstract]   [Full Text] [Related]  

  • 57. Photoaffinity labeling in neuroendocrine tissues.
    Hazum E
    Methods Enzymol; 1983; 103():58-71. PubMed ID: 6321897
    [No Abstract]   [Full Text] [Related]  

  • 58. Secondary drug failure occurring during chronic treatment with LHRH: appearance of an antibody.
    Van Loon GR; Brown GM
    J Clin Endocrinol Metab; 1975 Sep; 41(3):640-3. PubMed ID: 1099116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and purification of a receptor on macrophages for the dengue virus-induced suppressor cytokine.
    Mukherjee R; Chaturvedi P; Chaturvedi UC
    Clin Exp Immunol; 1993 Feb; 91(2):257-65. PubMed ID: 8381339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the porcine ACTH receptor with the aid of a monoclonal antibody.
    Lüddens H; Havsteen B
    Biol Chem Hoppe Seyler; 1986 Jul; 367(7):539-47. PubMed ID: 3019367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.